Application of cediranib in preparation of radiotherapy sensitizing drug
A cediranib and drug technology, applied in the application field of cediranib in the preparation of X-ray radiation sensitizing drugs, can solve problems such as fatigue
Inactive Publication Date: 2021-05-18
LANZHOU UNIVERSITY
View PDF0 Cites 0 Cited by
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Therefore, X-ray treatment may have side effects such as fatigue
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View moreImage
Smart Image Click on the blue labels to locate them in the text.
Smart ImageViewing Examples
Examples
Experimental program
Comparison scheme
Effect test
Embodiment
[0032] Example: Effects of cediranib combined with X-ray irradiation on tumor cell proliferation and apoptosis
[0033] method:
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more PUM
Login to view more Abstract
The invention discloses a new function of cediranib (CED), namely application of the cediranib (CED) in the technical field of tumor cell radiosensitization drugs in cooperation with X-ray radiation. A radiation sensitizer containing the cediranib has the effects of inhibiting tumor cell proliferation and inducing tumor cell apoptosis in cooperation with X-ray radiation. Therefore, the required radiation dose for X-ray irradiation on tumor cells can be reduced, and apoptosis of more tumor cells can be promoted. Therefore, the invention provides a potential application value of cediranib in preparation of radiotherapy sensitization drugs.
Description
technical field [0001] The present invention relates to a new application of cediranib (Cediranib, CED), in particular to the application of cediranib in the preparation of X-ray radiation sensitizing drugs. Background technique [0002] Lung cancer is one of the most common malignant tumors. In 2018, the number of new cases worldwide reached 2.09 million, and the number of deaths exceeded 1.76 million. The morbidity and mortality rank first among all cancers. Lung cancer is divided into non-small cell lung cancer and small cell lung cancer. Non-small cell lung cancer is the most common type, accounting for about 80%-85% of lung cancer cases. It has the characteristics of poor prognosis, and the five-year survival rate is less than 15% [Hirsch FR , Scagliotti GV, Mulshine JL, Kwon R, Curran WJ, Jr, WuYL, Paz-Ares L. Lung cancer: current therapies and new targeted treatments. Lancet 2017, 389: 299-311]. However, the incidence of lung cancer is hidden, more than 60% Most of t...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more Application Information
Patent Timeline
Login to view more Patent Type & Authority Applications(China)
IPC IPC(8): A61K31/517A61P35/00A61P35/04A61P43/00
CPCA61K31/517A61P35/00A61P35/04A61P43/00
Inventor 郭梦环甘露张红
Owner LANZHOU UNIVERSITY
Who we serve
- R&D Engineer
- R&D Manager
- IP Professional
Why Eureka
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Social media
Try Eureka
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap